A comprehensive test that analyses a patient’s complete set of genetic material “can transform cancer care” in the NHS by helping doctors provide them with more personalised treatments, scientists have said.
In the largest study of its kind, researchers have found that combining clinical health data with information gathered from whole-genome sequencing tests – which determines a person’s genetic make-up – can provide cancer patients with tailored care.
